A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis ...
The data could go some way to convince insurers and governments to reimburse Wegovy. Read more at straitstimes.com.
Wegovy, a relatively new drug approved by the US Food and Drug Administration (FDA) in June 2021, mimics the body’s GLP-1 ...
A Novo spokesperson said in a statement to Reuters that the new analysis "demonstrates for the first time the benefits of ...
The anti-diabetic medication “Ozempic” (semaglutide) made by Danish pharmaceutical company “Novo Nordisk”on February 23, 2023 ...
A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, ...
Novo Nordisk (NVO) claims it retains only 60% of list price of weight loss drugs Ozempic and Wegovy after payments to pharma ...
Researchers highlighted on Monday that certain genes may help identify patients with obesity who are most likely to respond ...
Global spending on obesity medications totaled $24 billion last year, IQVIA estimated in its latest five-year outlook, and ...
The study found that the majority of people on Wegovy lost weight, on average 10% of their body weight, in the first 15 ...
Patients sometimes have to stop using GLP-1 medications like Ozempic and Wegovy and risk regaining lost weight.
Recent research from the United States has raised serious concerns about the side effects of popular weight loss medications ...